Nucleoli as drivers of nuclear remodelling in cardiomyocytes during Heart Failure

This study reveals that nucleolar integrity and interactions are critical drivers of nuclear invagination formation in cardiomyocytes, and that the early loss of these structures during heart failure—preceding cytoskeletal stiffening and accompanied by nucleolar remodeling and DNA damage—suggests preserving nucleolar function as a novel therapeutic target.

The Gist

The Big Picture: The Heart's "Control Center" is Breaking Down

Imagine your heart is a massive, high-performance factory. For a long time, scientists thought the factory's problems (Heart Failure) were caused by broken conveyor belts (muscles) or tangled wires (cytoskeleton).

This new study suggests the real trouble is happening in the Factory's Control Room (the cell nucleus). Specifically, it's about a tiny, often-overlooked structure inside the Control Room called the Nucleolus (the "manager's office") and the tunnels (Nuclear Invaginations) that connect the office to the rest of the factory.

The Main Characters

1. The Nucleus (The Control Room): The command center of the heart cell. It holds the blueprints (DNA) and needs to talk to the rest of the cell to keep the heart beating.
2. Nuclear Invaginations (The Tunnels): Think of these as deep, double-walled tunnels or "subways" that fold into the Control Room. They are crucial because they act as elevators, shuttling important messages and materials (like Calcium, which tells the heart to squeeze) in and out of the Control Room.
3. The Nucleolus (The Manager's Office): A dense, round structure inside the Control Room where the blueprints are read and copied. The researchers discovered this isn't just a passive blob; it's a heavy, mechanical anchor that helps hold the tunnels open.

The Story of the Discovery

1. How the Tunnels Stay Open (The "Dual-Engine" Theory)

The scientists asked: What keeps these tunnels open and functional?
They found that the tunnels are held open by two forces working together:

• Outside the room: A scaffolding of "rods" (actin and microtubules) that pushes against the walls.
• Inside the room: The Nucleolus itself. It acts like a heavy anchor or a tension wire. It pushes against the tunnels from the inside, keeping them stretched open and ready for traffic.

The Analogy: Imagine a tent pole (the tunnel). It stays up because the ground is firm (the cytoskeleton) and because a heavy weight is pulling it tight from the inside (the nucleolus). If you remove the weight, the tent collapses.

2. What Happens When the Heart Fails?

The researchers looked at rats with heart failure (caused by a heart attack) and human patients with severe heart disease. They found a scary pattern:

• The Tunnels Disappear: In failing hearts, those vital "subway tunnels" vanish.
• The Consequence: Without tunnels, the "Control Room" gets cut off. Calcium (the signal to beat) gets stuck outside, and the inside of the nucleus gets flooded with too much calcium. This causes the heart cell to malfunction and eventually die.

3. The "Early Warning System" (The Big Surprise)

This is the most exciting part of the paper. Usually, scientists think heart failure starts with the muscles getting stiff and the "rods" breaking.

• The Old View: Muscles get stiff $\rightarrow$ Tunnels collapse.
• The New View: The Manager's Office (Nucleolus) gets sick first.

In the rat study, the scientists checked the hearts at 8 weeks and 16 weeks after a heart attack.

• At 8 weeks, the tunnels were already gone, but the "rods" (cytoskeleton) were still fine.
• What happened at 8 weeks? The Manager's Office (Nucleolus) started to change shape (becoming rounder and stiffer) and got damaged. It lost its ability to hold the tunnels open.
• The Result: The tunnels collapsed before the rest of the cell structure broke down.

Why Does This Matter?

Think of the heart failure process like a building collapsing.

• Before: We thought the building fell because the concrete walls (muscles) cracked first.
• Now: We realize the building fell because the foundation (the Nucleolus) shifted and cracked first, causing the roof (the tunnels) to cave in, which then brought the whole building down.

The Takeaway for the Future

This study changes how we might treat heart failure in the future.

• Old Strategy: Try to fix the stiff muscles or the broken rods.
• New Strategy: Protect the Nucleolus. If we can keep the "Manager's Office" healthy and flexible, we might be able to keep the "tunnels" open, even if the heart is under stress. This could stop the heart failure from getting worse much earlier in the disease process.

In short: The heart's control room has a hidden manager (the nucleolus) that holds the doors open. When the heart gets sick, this manager gets stressed and stiffens up, slamming the doors shut. Keeping the manager healthy might be the key to saving the heart.

Technical Summary

1. Problem Statement

Cardiomyocyte mechanotransduction has historically focused on the sarcomere and cytoskeleton. However, emerging evidence suggests the nucleus is an active mechanical responder. A key nuclear adaptation is the formation of Nuclear Invaginations (NIs)—deep, double-membrane folds that extend into the nucleoplasm. NIs function as "nuclear T-tubules," facilitating nucleo-cytoplasmic transport (including Ca²⁺) and providing structural support to chromatin.

• The Gap: While NIs are known to be depleted in end-stage Heart Failure (HF), the regulatory mechanisms governing their formation and the specific timeline of their loss during disease progression remain unclear. It is unknown whether NI loss is a primary driver of dysfunction or a secondary consequence of cytoskeletal stiffening.

2. Methodology

The study employed a multi-modal approach combining high-resolution imaging, pharmacological manipulation, animal models, and human tissue samples:

• Animal Models:
  • Acute/Subacute/Chronic HF: Adult male Sprague-Dawley rats subjected to Myocardial Infarction (MI) via proximal coronary ligation. Samples were analyzed at 8 weeks (early remodeling) and 16 weeks (end-stage HF).
  • Human Samples: Left ventricular tissue from donors and patients with end-stage Dilated Cardiomyopathy (DCM).
• Cell Isolation & Treatment: Adult rat cardiomyocytes were isolated via Langendorff perfusion. Cells were treated with:
  • Cytochalasin D (CytD): To disrupt actin filaments.
  • Parthenolide (PTL): To reduce detyrosinated microtubules (detyrMT).
  • BMH21: An RNA polymerase I inhibitor to induce nucleolar stress and reduce nucleolar size.
• Imaging & Biophysical Techniques:
  • High-Resolution Microscopy: Confocal and Spinning Disc microscopy (Nikon Ti2 SoRa) for immunocytochemistry (staining for actin, detyrMT, nucleolin, nucleophosmin, γH2AX).
  • Ca²⁺ Imaging: Line-scan confocal microscopy using Fluo-4/AM to measure simultaneous cytoplasmic and nucleoplasmic Ca²⁺ transients.
  • mechano-Scanning Ion Conductance Microscopy (mechanoSICM): Used to map topography and Young's Modulus (stiffness) non-invasively.
  • Brillouin Micro-spectroscopy: A non-destructive, contact-free technique to measure the longitudinal elastic modulus (stiffness) of nucleoli in situ.
• Quantification: NI density was normalized to nuclear perimeter; chromocenter-nucleolin overlap was quantified using Manders' coefficients (M1/M2).

3. Key Contributions & Findings

A. Mechanisms Regulating NI Formation (Physiological Conditions)

• Cytoskeletal Dependence: NIs are regulated by the actin cytoskeleton and detyrosinated microtubules (detyrMT).
  • Disruption of actin (CytD) or detyrMT (PTL) significantly reduced NI numbers.
  • Standard microtubule disruption had no effect, highlighting the specific role of detyrMT.
• Nucleolar Interaction: NIs physically extend to the nucleolus. Inducing nucleolar stress (BMH21) reduced nucleolar area and circularity, leading to a concurrent decline in NIs.
• Functional Consequence: Disruption of NIs (via PTL or CytD) did not alter cytoplasmic Ca²⁺ transients but caused a significant elevation in baseline nucleoplasmic Ca²⁺, particularly at high pacing frequencies. This confirms NIs are active organizers of nuclear Ca²⁺ homeostasis.

B. Temporal Dynamics in Heart Failure (Pathological Conditions)

• Early NI Loss: In the rat MI model, a marked reduction in NIs was observed at 8 weeks post-MI. This occurred before detectable changes in cytoskeletal stiffness or detyrMT levels (which typically change in later stages).
• Human Correlation: End-stage human DCM samples showed a robust depletion of NIs, confirming the finding in chronic human disease.
• Nucleolar Remodelling Precedes Cytoskeletal Stiffening: At the 8-week mark (early HF):
  • Morphology: Nucleoli became more circular (altered interfacial tension).
  • Chromatin Organization: There was an accumulation of chromocentres (repressive heterochromatin) surrounding the nucleolus, overlapping with γH2AX foci (indicating DNA damage).
  • Biomechanics: Brillouin microscopy revealed a statistically significant increase in nucleolar stiffness (Brillouin shift) at 8 weeks, preceding major cytoskeletal changes.

4. Significance and Conclusion

• Paradigm Shift: The study challenges the view that nuclear remodeling is solely a passive result of extracellular matrix or cytoskeletal stiffening. Instead, it identifies the nucleolus as an active mechanical driver of nuclear architecture.
• Mechanistic Insight: The data suggests a dual mechanism for NI formation: coordinated forces from the cytoskeleton (detyrMT/actin) and intranuclear interactions with the nucleolus.
• Clinical Implication: The loss of NIs and the associated disruption of nuclear Ca²⁺ homeostasis occur early in the disease trajectory (8 weeks), driven by nucleolar stiffening and DNA damage.
• Therapeutic Target: Preserving nucleolar integrity and preventing early nucleolar stiffening could be a novel therapeutic strategy to mitigate adverse cardiac remodeling and prevent the progression to end-stage Heart Failure.

In summary: This paper establishes that nucleolar remodelling and stiffening are early events in Heart Failure that drive the loss of nuclear invaginations, leading to nuclear Ca²⁺ dysregulation and DNA damage, independent of early cytoskeletal changes.